Cases
BioPhenyx is currently serving customers ranging from big pharma to small-scale biotech enterprises and works with partners in the clinic.
Case 1
Customer has doubts as to which of several identified intracellular targets to inhibit by therapy. Which target has the major role in the disease? BioPhenyx helps to clarify.
Case 2
Customer has identified an intracellular target, which may play a role in disease mechanism – however no previous method has been able to clearly verify or reject the hypothesis. BioPhenyx helps to clarify.
Case 3
Customer has for years worked with a particular target that is believed to play a role in disease development and tested this from different technological angles without conclusive results. BioPhenyx helps to clarify.
Case 4
Customer has a proprietary drug in development, however, has doubts regarding the target population, as determined by genetic sequence variations (genetic biomarkers). BioPhenyx helps to clarify.
Case 5
Partner believes that a sub-group of patients do not receive adequate therapy based on current technologies used to stratify patients for treatment. BioPhenyx helps to clarify.